Octapharma licenses Glycotope's coagulation factors

Glycotope GmbH (Berlin, Germany) granted Octapharma AG (Lachen, Switzerland) exclusive, worldwide rights to develop preclinical human blood coagulation factors based on Glycotope's GlycoExpress platform.

Glycotope's technology consists of glycoengineered human suspension cell lines which are used to produce complex proteins with human and tailored glycosylation patterns. ...